文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.

作者信息

Krause Arthur, Roma Luca, Lorber Thomas, Habicht James, Lardinois Didier, De Filippo Maria Rosaria, Prince Spasenija Savic, Piscuoglio Salvatore, Ng CharlotteKY, Bubendorf Lukas

机构信息

Institute of Molecular Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland.

Thoracic Surgery, St. Clara Hospital, Basel, Switzerland.

出版信息

Lung Cancer. 2020 Dec;150:132-138. doi: 10.1016/j.lungcan.2020.10.013. Epub 2020 Oct 29.


DOI:10.1016/j.lungcan.2020.10.013
PMID:33137577
Abstract

Adenosquamous carcinoma of the lung (ASC) is a rare subtype of non-small cell lung cancer, consisting of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) components. ASC shows morphological characteristics of classic LUAD and LUSC but behaves more aggressively. Although ASC can serve as a model of lung cancer heterogeneity and transdifferentiation, its genomic background remains poorly understood. In this study, we sought to explore the genomic landscape of macrodissected LUAD and LUSC components of three ASC using whole exome sequencing (WES). Identified truncal mutations included the pan-cancer tumor-suppressor gene TP53 but also EGFR, BRAF, and MET, which are characteristic for LUAD but uncommon in LUSC. No truncal mutation of classical LUSC driver mutations were found. Both components showed unique driver mutations that did not overlap between the three ASC. Mutational signatures of truncal mutations differed from those of the branch mutations in their descendants LUAD and LUSC. Most common signatures were related to aging (1, 5) and smoking (4). Truncal chromosomal copy number aberrations shared by all three ASC included losses of 3p, 15q and 19p, and an amplified region in 5p. Furthermore, we detected loss of STK11 and SOX2 amplification in ASC, which has previously been shown to drive transdifferentiation from LUAD to LUSC in preclinical mouse models. Conclusively, this is the first study using WES to elucidate the clonal evolution of ASC. It provides strong evidence that the LUAD and LUSC components of ASC share a common origin and that the LUAD component appears to transform to LUSC.

摘要

相似文献

[1]
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.

Lung Cancer. 2020-12

[2]
Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.

Biochem Biophys Res Commun. 2018-8-9

[3]
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation.

J Hematol Oncol. 2021-10-16

[4]
Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.

Thorac Cancer. 2020-1

[5]
Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.

J Clin Lab Anal. 2021-2

[6]
System analysis of in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.

Int J Biol Markers. 2022-6

[7]
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.

Mol Cancer. 2019-1-9

[8]
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.

J Cell Physiol. 2018-12-13

[9]
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma.

Neoplasia. 2023-11

[10]
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Front Endocrinol (Lausanne). 2021

引用本文的文献

[1]
Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review.

Front Immunol. 2025-6-26

[2]
Tracking the Evolution of Cutaneous Melanoma by Multiparameter Flow Sorting and Genomic Profiling.

Int J Mol Sci. 2025-2-19

[3]
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.

J Exp Med. 2024-7-1

[4]
In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma.

Front Oncol. 2024-1-25

[5]
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma.

NPJ Precis Oncol. 2023-8-26

[6]
Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review.

Transl Lung Cancer Res. 2023-4-28

[7]
Targeted therapy for rare lung cancers: Status, challenges, and prospects.

Mol Ther. 2023-7-5

[8]
Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion.

Front Oncol. 2022-12-1

[9]
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment.

Natl Sci Rev. 2023-2-14

[10]
Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation.

Signal Transduct Target Ther. 2023-1-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索